Discontinued — last reported Q3 '24
Cigna Fees — Revenue increased by 2.5% to $5.00B in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $4.50B to $5.00B. Over 2 years (FY 2021 to FY 2023), Fees — Revenue shows an upward trend with a 21.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in service-based business volume or higher penetration of administrative service offerings, while a decrease may signal contract losses or pricing pressure in the PBM and specialty pharmacy segments.
This metric represents the total revenue generated from service-based contracts where the company acts as a service prov...
Peers in the managed care and PBM space, such as CVS Health or UnitedHealth Group, report similar service-based revenue streams, though accounting classifications for 'fees' versus 'premiums' can vary based on the specific contract structure.
ci_segment_fees_revenue_from_contract_with_customer| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.35B | $2.51B | $4.65B | $3.13B | $3.27B | $3.41B | $3.49B | $4.11B | $4.44B | $4.50B | $4.39B | $4.54B | $4.88B | $5.00B |
| QoQ Change | — | +7.2% | +84.9% | -32.8% | +4.7% | +4.1% | +2.6% | +17.5% | +8.2% | +1.4% | -2.6% | +3.5% | +7.4% | +2.5% |
| YoY Change | — | — | — | — | +39.5% | +35.5% | -24.8% | +31.4% | +35.7% | +32.2% | +25.5% | +10.5% | +9.8% | +11.1% |